Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HFP0
Term | Name | Level | Count |
---|---|---|---|
GO:0006417 | regulation of translation | 6 | 1 |
GO:0006449 | regulation of translational termination | 6 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009891 | positive regulation of biosynthetic process | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 6 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0010629 | negative regulation of gene expression | 6 | 1 |
GO:0018126 | protein hydroxylation | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0031328 | positive regulation of cellular biosynthetic process | 6 | 1 |
GO:0034248 | regulation of amide metabolic process | 5 | 1 |
GO:0034250 | positive regulation of amide metabolic process | 6 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043243 | positive regulation of protein-containing complex disassembly | 6 | 1 |
GO:0043244 | regulation of protein-containing complex disassembly | 5 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045727 | positive regulation of translation | 7 | 1 |
GO:0045905 | positive regulation of translational termination | 7 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048522 | positive regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051128 | regulation of cellular component organization | 4 | 1 |
GO:0051130 | positive regulation of cellular component organization | 5 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051246 | regulation of protein metabolic process | 5 | 1 |
GO:0051247 | positive regulation of protein metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:2000112 | obsolete regulation of cellular macromolecule biosynthetic process | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003677 | DNA binding | 4 | 1 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0016491 | oxidoreductase activity | 2 | 1 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 1 |
GO:0016706 | 2-oxoglutarate-dependent dioxygenase activity | 4 | 1 |
GO:0043565 | sequence-specific DNA binding | 5 | 1 |
GO:0051213 | dioxygenase activity | 3 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 194 | 198 | PF00656 | 0.360 |
CLV_C14_Caspase3-7 | 33 | 37 | PF00656 | 0.248 |
CLV_C14_Caspase3-7 | 451 | 455 | PF00656 | 0.474 |
CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 346 | 348 | PF00675 | 0.598 |
CLV_NRD_NRD_1 | 468 | 470 | PF00675 | 0.419 |
CLV_NRD_NRD_1 | 47 | 49 | PF00675 | 0.404 |
CLV_PCSK_KEX2_1 | 173 | 175 | PF00082 | 0.433 |
CLV_PCSK_KEX2_1 | 345 | 347 | PF00082 | 0.422 |
CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.468 |
CLV_PCSK_KEX2_1 | 468 | 470 | PF00082 | 0.419 |
CLV_PCSK_PC1ET2_1 | 173 | 175 | PF00082 | 0.313 |
CLV_PCSK_PC1ET2_1 | 46 | 48 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 295 | 299 | PF00082 | 0.310 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.430 |
DOC_CDC14_PxL_1 | 312 | 320 | PF14671 | 0.415 |
DOC_CKS1_1 | 288 | 293 | PF01111 | 0.506 |
DOC_MAPK_gen_1 | 345 | 354 | PF00069 | 0.418 |
DOC_MAPK_gen_1 | 468 | 474 | PF00069 | 0.242 |
DOC_MAPK_MEF2A_6 | 110 | 118 | PF00069 | 0.350 |
DOC_PP4_FxxP_1 | 288 | 291 | PF00568 | 0.515 |
DOC_USP7_MATH_1 | 128 | 132 | PF00917 | 0.591 |
DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.511 |
DOC_USP7_MATH_1 | 242 | 246 | PF00917 | 0.470 |
DOC_USP7_MATH_1 | 289 | 293 | PF00917 | 0.502 |
DOC_USP7_MATH_1 | 350 | 354 | PF00917 | 0.706 |
DOC_WW_Pin1_4 | 160 | 165 | PF00397 | 0.401 |
DOC_WW_Pin1_4 | 212 | 217 | PF00397 | 0.665 |
DOC_WW_Pin1_4 | 244 | 249 | PF00397 | 0.417 |
DOC_WW_Pin1_4 | 287 | 292 | PF00397 | 0.506 |
DOC_WW_Pin1_4 | 78 | 83 | PF00397 | 0.650 |
LIG_APCC_ABBA_1 | 331 | 336 | PF00400 | 0.272 |
LIG_BRCT_BRCA1_1 | 257 | 261 | PF00533 | 0.515 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.422 |
LIG_deltaCOP1_diTrp_1 | 194 | 199 | PF00928 | 0.313 |
LIG_deltaCOP1_diTrp_1 | 266 | 271 | PF00928 | 0.424 |
LIG_eIF4E_1 | 279 | 285 | PF01652 | 0.520 |
LIG_FHA_1 | 152 | 158 | PF00498 | 0.548 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.389 |
LIG_FHA_1 | 339 | 345 | PF00498 | 0.566 |
LIG_FHA_1 | 366 | 372 | PF00498 | 0.392 |
LIG_FHA_1 | 399 | 405 | PF00498 | 0.409 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.606 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.465 |
LIG_FHA_2 | 288 | 294 | PF00498 | 0.458 |
LIG_FHA_2 | 296 | 302 | PF00498 | 0.415 |
LIG_FHA_2 | 454 | 460 | PF00498 | 0.507 |
LIG_FHA_2 | 93 | 99 | PF00498 | 0.698 |
LIG_LIR_Apic_2 | 182 | 188 | PF02991 | 0.370 |
LIG_LIR_Apic_2 | 266 | 272 | PF02991 | 0.424 |
LIG_LIR_Gen_1 | 234 | 243 | PF02991 | 0.250 |
LIG_LIR_Gen_1 | 431 | 439 | PF02991 | 0.438 |
LIG_LIR_Gen_1 | 476 | 482 | PF02991 | 0.474 |
LIG_LIR_Gen_1 | 8 | 19 | PF02991 | 0.292 |
LIG_LIR_Nem_3 | 245 | 249 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 252 | 257 | PF02991 | 0.479 |
LIG_LIR_Nem_3 | 476 | 481 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 8 | 14 | PF02991 | 0.320 |
LIG_LYPXL_S_1 | 66 | 70 | PF13949 | 0.243 |
LIG_Pex14_1 | 195 | 199 | PF04695 | 0.309 |
LIG_Pex14_1 | 375 | 379 | PF04695 | 0.424 |
LIG_SH2_CRK | 185 | 189 | PF00017 | 0.362 |
LIG_SH2_CRK | 239 | 243 | PF00017 | 0.473 |
LIG_SH2_CRK | 320 | 324 | PF00017 | 0.480 |
LIG_SH2_CRK | 478 | 482 | PF00017 | 0.372 |
LIG_SH2_STAP1 | 257 | 261 | PF00017 | 0.424 |
LIG_SH2_STAP1 | 478 | 482 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 279 | 282 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 441 | 444 | PF00017 | 0.211 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.315 |
LIG_SH3_3 | 283 | 289 | PF00018 | 0.529 |
LIG_SH3_3 | 303 | 309 | PF00018 | 0.416 |
LIG_SH3_3 | 310 | 316 | PF00018 | 0.415 |
LIG_SH3_3 | 62 | 68 | PF00018 | 0.445 |
LIG_SUMO_SIM_anti_2 | 400 | 410 | PF11976 | 0.404 |
LIG_TRAF2_1 | 340 | 343 | PF00917 | 0.415 |
LIG_TYR_ITIM | 318 | 323 | PF00017 | 0.253 |
LIG_WRC_WIRS_1 | 196 | 201 | PF05994 | 0.385 |
LIG_WRC_WIRS_1 | 351 | 356 | PF05994 | 0.415 |
MOD_CDK_SPxxK_3 | 78 | 85 | PF00069 | 0.553 |
MOD_CK1_1 | 120 | 126 | PF00069 | 0.418 |
MOD_CK1_1 | 156 | 162 | PF00069 | 0.571 |
MOD_CK1_1 | 166 | 172 | PF00069 | 0.565 |
MOD_CK1_1 | 198 | 204 | PF00069 | 0.427 |
MOD_CK1_1 | 212 | 218 | PF00069 | 0.448 |
MOD_CK1_1 | 353 | 359 | PF00069 | 0.486 |
MOD_CK1_1 | 397 | 403 | PF00069 | 0.476 |
MOD_CK1_1 | 431 | 437 | PF00069 | 0.389 |
MOD_CK1_1 | 57 | 63 | PF00069 | 0.435 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.649 |
MOD_CK2_1 | 295 | 301 | PF00069 | 0.273 |
MOD_CK2_1 | 453 | 459 | PF00069 | 0.462 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.460 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.469 |
MOD_GlcNHglycan | 326 | 329 | PF01048 | 0.300 |
MOD_GlcNHglycan | 355 | 358 | PF01048 | 0.626 |
MOD_GlcNHglycan | 363 | 366 | PF01048 | 0.540 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.446 |
MOD_GSK3_1 | 145 | 152 | PF00069 | 0.348 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.467 |
MOD_GSK3_1 | 253 | 260 | PF00069 | 0.284 |
MOD_GSK3_1 | 361 | 368 | PF00069 | 0.487 |
MOD_GSK3_1 | 393 | 400 | PF00069 | 0.422 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.575 |
MOD_N-GLC_1 | 324 | 329 | PF02516 | 0.355 |
MOD_N-GLC_1 | 425 | 430 | PF02516 | 0.477 |
MOD_N-GLC_2 | 262 | 264 | PF02516 | 0.284 |
MOD_N-GLC_2 | 29 | 31 | PF02516 | 0.449 |
MOD_N-GLC_2 | 374 | 376 | PF02516 | 0.280 |
MOD_NEK2_1 | 149 | 154 | PF00069 | 0.439 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.476 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.281 |
MOD_PIKK_1 | 130 | 136 | PF00454 | 0.506 |
MOD_PIKK_1 | 163 | 169 | PF00454 | 0.528 |
MOD_PKA_1 | 174 | 180 | PF00069 | 0.278 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.505 |
MOD_Plk_1 | 428 | 434 | PF00069 | 0.374 |
MOD_Plk_4 | 301 | 307 | PF00069 | 0.279 |
MOD_ProDKin_1 | 160 | 166 | PF00069 | 0.396 |
MOD_ProDKin_1 | 212 | 218 | PF00069 | 0.662 |
MOD_ProDKin_1 | 244 | 250 | PF00069 | 0.256 |
MOD_ProDKin_1 | 287 | 293 | PF00069 | 0.380 |
MOD_ProDKin_1 | 78 | 84 | PF00069 | 0.647 |
MOD_SUMO_for_1 | 96 | 99 | PF00179 | 0.488 |
TRG_ENDOCYTIC_2 | 11 | 14 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 320 | 323 | PF00928 | 0.344 |
TRG_ENDOCYTIC_2 | 478 | 481 | PF00928 | 0.477 |
TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.254 |
TRG_ER_diArg_1 | 344 | 347 | PF00400 | 0.418 |
TRG_ER_diArg_1 | 467 | 469 | PF00400 | 0.434 |
TRG_ER_diArg_1 | 47 | 49 | PF00400 | 0.462 |
TRG_NES_CRM1_1 | 293 | 303 | PF08389 | 0.393 |
TRG_Pf-PMV_PEXEL_1 | 189 | 194 | PF00026 | 0.376 |
TRG_Pf-PMV_PEXEL_1 | 468 | 473 | PF00026 | 0.327 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I519 | Leptomonas seymouri | 50% | 92% |
A0A0S4JI40 | Bodo saltans | 30% | 98% |
A0A1X0P4A9 | Trypanosomatidae | 37% | 100% |
A0A3R7LP24 | Trypanosoma rangeli | 38% | 100% |
A0A3S7X0M0 | Leishmania donovani | 76% | 100% |
A4I2R6 | Leishmania infantum | 76% | 100% |
D0A5X2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AD93 | Leishmania major | 77% | 100% |
E9AZ18 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
Q08BY5 | Danio rerio | 24% | 100% |
V5BD54 | Trypanosoma cruzi | 39% | 100% |